| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Johns Hopkins Oncology Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231 [R. A. C., S. J. E., P. C., S. B. B.], and The Department of Medicinal Chemistry, J. Hillis Miller Health Center, University of Florida, Gainesville, Florida 32610 [R. J. B.]
We have compared the effects of treatment with each of three bis(ethyl)polyamine analogues on a human small cell lung carcinoma (SCLC) line, NCI H82, and a non-small cell line, NCI H157, an undifferentiated large cell lung carcinoma. The bis(ethyl)polyamines have been shown to interfere with polyamine metabolism, presumably by regulation of the polyamine biosynthetic pathway in a manner similar to the natural polyamines, in contrast to direct inhibition of specific enzymes, such as ornithine decarboxylase. Each of these compounds was found to be relatively inactive in reducing growth rate, polyamine levels, or polyamine biosynthetic enzyme activity in the SCLC cells, a line which we have previously shown to be particularly sensitive to inhibition of polyamine biosynthesis by the direct ornithine decarboxylase inhibitor difluoromethylornithine. By contrast, each of the bis(ethyl)polyamines tested was found to be markedly cytotoxic (at concentrations of only 10 µM) to the non-SCLC line, NCI H157. Interestingly, the non-SCLC line has previously been demonstrated to be resistant to polyamine depletion by difluoromethylornithine. For each bis(ethyl)polyamine, cytotoxicity was accompanied by nearly complete depletion of all intracellular polyamines and a decrease in ornithine decarboxylase activity to undetectable levels. The current study emphasizes the phenotypic variability which can exist in response to inhibitors of polyamine biosynthesis and suggests a class of agents which may have clinical utility against the treatment-resistant non-SCLC lung cancers.
1 This work was supported by NIH Grants CA37606 and CA47492.
2 To whom requests for reprints should be addressed, at The Johns Hopkins Oncology Center Laboratories, 424 North Bond Street, Baltimore, MD 21231.
Received 8/15/88. Revised 10/21/88. Accepted 10/28/88.
This article has been cited by other articles:
![]() |
N. Babbar, A. Hacker, Y. Huang, and R. A. Casero Jr. Tumor Necrosis Factor {alpha} Induces Spermidine/Spermine N1-Acetyltransferase through Nuclear Factor {kappa}Bin Non-small Cell Lung Cancer Cells J. Biol. Chem., August 25, 2006; 281(34): 24182 - 24192. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Bewley, V. Graziano, J. Jiang, E. Matz, F. W. Studier, A. E. Pegg, C. S. Coleman, and J. M. Flanagan Structures of wild-type and mutant human spermidine/spermine N1-acetyltransferase, a potential therapeutic drug target PNAS, February 14, 2006; 103(7): 2063 - 2068. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lindemose, P. E. Nielsen, and N. E. Mollegaard Polyamines preferentially interact with bent adenine tracts in double-stranded DNA Nucleic Acids Res., March 23, 2005; 33(6): 1790 - 1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. I. Bussiere, R. Chaturvedi, Y. Cheng, A. P. Gobert, M. Asim, D. R. Blumberg, H. Xu, P. Y. Kim, A. Hacker, R. A. Casero Jr., et al. Spermine Causes Loss of Innate Immune Response to Helicobacter pylori by Inhibition of Inducible Nitric-oxide Synthase Translation J. Biol. Chem., January 28, 2005; 280(4): 2409 - 2412. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kee, B. A. Foster, S. Merali, D. L. Kramer, M. L. Hensen, P. Diegelman, N. Kisiel, S. Vujcic, R. V. Mazurchuk, and C. W. Porter Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice J. Biol. Chem., September 17, 2004; 279(38): 40076 - 40083. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chaturvedi, Y. Cheng, M. Asim, F. I. Bussiere, H. Xu, A. P. Gobert, A. Hacker, R. A. Casero Jr., and K. T. Wilson Induction of Polyamine Oxidase 1 by Helicobacter pylori Causes Macrophage Apoptosis by Hydrogen Peroxide Release and Mitochondrial Membrane Depolarization J. Biol. Chem., September 17, 2004; 279(38): 40161 - 40173. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kee, S. Vujcic, S. Merali, P. Diegelman, N. Kisiel, C. T. Powell, D. L. Kramer, and C. W. Porter Metabolic and Antiproliferative Consequences of Activated Polyamine Catabolism in LNCaP Prostate Carcinoma Cells J. Biol. Chem., June 25, 2004; 279(26): 27050 - 27058. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Wolff, D. K. Armstrong, J. H. Fetting, M. K. Carducci, C. D. Riley, J. F. Bender, R. A. Casero Jr., and N. E. Davidson A Phase II Study of the Polyamine Analog N1,N11-Diethylnorspermine (DENSpm) Daily for Five Days Every 21 Days in Patients with Previously Treated Metastatic Breast Cancer Clin. Cancer Res., December 1, 2003; 9(16): 5922 - 5928. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Carlisle, W. L. Devereux, A. Hacker, P. M. Woster, and R. A. Casero Jr. Growth Status Significantly Affects the Response of Human Lung Cancer Cells to Antitumor Polyamine-Analogue Exposure Clin. Cancer Res., August 1, 2002; 8(8): 2684 - 2689. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Hahm, D. S. Ettinger, K. Bowling, B. Hoker, T. L. Chen, Y. Zabelina, and R. A. Casero Jr. Phase I Study of N1,N11-Diethylnorspermine in Patients with Non-Small Cell Lung Cancer Clin. Cancer Res., March 1, 2002; 8(3): 684 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. McCloskey, P. M. Woster, R. A. Casero Jr., and N. E. Davidson Effects of the Polyamine Analogues N1 -Ethyl-N11-((cyclopropyl)methyl)-4,8-diazaundecane and N1-Ethyl-N11-((cycloheptyl)methyl)-4,8- diazaundecane in Human Prostate Cancer Cells Clin. Cancer Res., January 1, 2000; 6(1): 17 - 23. [Abstract] [Full Text] |
||||
![]() |
E. W. Gabrielson, A. E. Pegg, and R. A. Casero Jr. The Induction of Spermidine/Spermine N1-Acetyltransferase (SSAT) Is a Common Event in the Response of Human Primary Non-Small Cell Lung Carcinomas to Exposure to the New Antitumor Polyamine Analogue N1,N11-Bis(ethyl)norspermine1 Clin. Cancer Res., July 1, 1999; 5(7): 1638 - 1641. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. McCloskey and A. E. Pegg Altered Spermidine/Spermine N1-Acetyltransferase Activity as a Mechanism of Cellular Resistance to Bis(ethyl)polyamine Analogues J. Biol. Chem., September 8, 2000; 275(37): 28708 - 28714. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |